Furiex Pharmaceuticals (FURX) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts FURX Hot Sheet
Join SI Premium – FREE
Furiex Pharmaceuticals (Nasdaq: FURX) reported Q1 loss of $0.87, versus ($1.45) last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Procter & Gamble (PG) Tops Q3 EPS by 11c, Revenues Miss
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
